Treatment group | Control group | p | |
---|---|---|---|
Charlson comorbidity index | 4,91 ± 1,67 | 5,09 ± 1,58 | 0,59 |
Myocardial infarction | 8 | 9 | 0,73 |
Congestive heart failure | 24 | 28 | 0,37 |
Peripheral disease | 43 | 36 | 0,14 |
Cerebrovascular disease | 28 | 24 | 0,35 |
Dementia | 3 | 6 | 0,21 |
Chronic pulmonary disease | 9 | 13 | 0,23 |
Connective tissue disease | 2 | 5 | 0,17 |
Peptic ulcer disease | 13 | 19 | 0,12 |
Mild liver disease | 11 | 18 | 0,07 |
Diabetes without end-organ damage | 10 | 11 | 0,75 |
Hemiplegia | 4 | 2 | 0,15 |
Moderate or severe renal disease | 96 | 96 | – |
Diabetes with end-organ damage | 2 | 3 | 0,56 |
Tumor without metastasis | 4 | 3 | 0,61 |
Leukemia | 1 | 1 | – |
Lymphoma | 1 | 1 | – |
Moderate or severe liver disease | 3 | 4 | 0,61 |
Metastatic solid tumor | 0 | 0 | – |
AIDS | 0 | 0 | – |